What is CBG Biotech?
CBG Biotech operates as a premier manufacturer and supplier of advanced solvent recovery and recycling systems. With a legacy spanning over two decades, the organization provides essential infrastructure for laboratory, industrial, and cannabis extraction applications. Their core value proposition centers on the integration of sustainable practices into high-volume chemical processes, effectively reducing hazardous air pollutant (HAP) exposure while simultaneously driving down operational costs for their diverse client base. By offering a comprehensive suite of HAP-free solvents and high-efficiency extraction hardware, CBG Biotech serves as a vital partner for enterprises aiming to optimize their environmental footprint without compromising on technical performance or safety standards.
How much funding has CBG Biotech raised?
CBG Biotech has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in CBG Biotech
PPP
Public-Private Partnership
What's next for CBG Biotech?
With the recent infusion of capital, CBG Biotech is poised to scale its manufacturing capabilities and expand its reach into emerging industrial markets. The strategic focus will likely shift toward the refinement of its automated recycling systems, ensuring that the company remains at the forefront of green technology adoption. As regulatory pressures regarding chemical waste management intensify globally, CBG Biotech is strategically aligned to capture increased market share by providing scalable, cost-effective, and compliant solutions. Future growth trajectories will likely involve the integration of smart-monitoring technologies within their existing hardware, further cementing their reputation as a leader in sustainable chemical lifecycle management.
See full CBG Biotech company page
